Target intelligence / Profile preview

Siderophore-mediated iron transport system (SMITS)

Target
SMITS
Molecular classification
Transporter, Outer membrane receptor, TonB-dependent receptor, Bacterial protein complex
01

Overview

The Siderophore-mediated iron transport system is a specialized bacterial machinery used to scavenge ferric iron (Fe3+) from the host environment, where it is typically sequestered by proteins like transferrin and lactoferrin (PMID: 20453874). This system consists of secreted high-affinity chelators called siderophores and their corresponding TonB-dependent receptors (TBDTs) located on the outer membrane of Gram-negative bacteria (UniProt: TonB-dependent receptor family). Upon binding the iron-siderophore complex, the receptor undergoes a conformational change, powered by the TonB-ExbB-ExbD complex, to internalize the iron into the periplasm (PMID: 30111631). This pathway is a critical virulence factor, as iron is essential for bacterial metabolism, DNA synthesis, and biofilm formation. In drug development, this system is exploited through the "Trojan Horse" strategy, where an antibiotic is chemically linked to a siderophore moiety. The most prominent example is Cefiderocol, which utilizes these transporters to bypass the outer membrane, achieving high concentrations at its target site even in multidrug-resistant strains like Pseudomonas aeruginosa (PMID: 31932312).

Other names
Siderophore-iron uptake systemTonB-dependent transport systemBacterial iron acquisition pathwayIron transport via siderophore bindingGO:0033212
02

Mechanism of action

Siderophore-mediated active transport (Trojan Horse mechanism) utilizing TonB-dependent receptors to bypass the bacterial outer membrane permeability barrier.

03

Biological functions

Iron homeostasisBacterial growthPathogenesisNutrient acquisitionVirulence factor regulation
04

Disease associations

Bacterial infectionGram-negative bacterial infectionMultidrug-resistant (MDR) infectionSepsisPneumonia
05

Safety considerations

Development of resistance through receptor down-regulation or mutationPotential for reduced efficacy in iron-rich environmentsMutations in the TonB-ExbB-ExbD energy-coupling complexCross-resistance between different siderophore-drug conjugates
06

Interacting drugs

Cefiderocol

3 more in the full profile.

07

Biomarkers

TonB-dependent receptor expression (e.g., PiuA, PirA, CirA, Fiu)Siderophore production levelsBacterial iron-starvation response genesTonB complex gene expression

Beyond the preview

Go deeper on Siderophore-mediated iron transport system (SMITS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siderophore-mediated iron transport system (SMITS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call